Article in Medical Technology

We are delighted to be in print in issue 18 of Medical Technology. The article is entitled ‘Destroying tumours with next-generation ablation’, here’s brief intro, click here to read the full article. “Radiofrequency ablation (RFA) can destroy solid tumours without the need for invasive surgery. At the forefront is NHS Norfolk and Norwich University Hospital […]

Healthcare revolution: The ten health innovations that could soon be on the NHS

In the 70 years since the NHS was established, medical breakthroughs such as MRI scanners, IVF and dialysis machines have transformed the health service and people’s lives. And while it’s impossible to predict how things will change over the next seven decades experts such as NHS England’s health innovation chief Professor Tony Young are predicting […]

Award nomination for New Anglia Capital investee Ablatus

Norfolk and Norwich University Hospital spin-out Ablatus Therapeutics has been shortlisted for the esteemed UK Business Angels Association (UKBAA) Angel Investment Awards. The awards will celebrate 2018’s high-growth entrepreneur success stories and the investors behind them and will be presented at a glittering ceremony on 19th June, in Liverpool Cathedral. Ablation uses heat generated by electric […]

Breaking down the barriers

Despite the Governments recent Accelerated Access Review – barriers to adoption of new technology in the NHS is still stifling medical innovation. We need a mind-set change says Dr Anne Blackwood. For many onlookers, curing cancer is one of medical research’s holy grails – a top-level goal that has been in the crosshairs for decades and […]

NVM Private Equity leads investment in Ablatus Therapeutics

NVM Private Equity (“NVM”) has invested £1.0 million of growth capital into Cambridge-based medical device company Ablatus Therapeutics Limited (“Ablatus”) alongside existing angel investors. Ablatus was founded in 2016 as a spin out from the NHS, under the guidance of Health Enterprise East (HEE), to develop and commercialise patented Bimodal Electric Tissue Ablation (BETA) technology. […]

East Anglia’s angel investor fund has been given a £1m top-up to support young businesses

A venture capital fund backing some of the region’s high-growth business prospects has received a million-pound top-up to invest in more start-ups. The funding for New Anglia Local Enterprise Partnership’s angel investment programme New Anglia Capital (NAC) means that the LEP has now allocated £3m to the project. NAC is a co-investment fund with New […]

Norwich’s Ablatus Therapeutics and Queen Elizabeth Hospital’s Safira project given cash injection

A company fighting cancer, a device to stop sleep disorder and a project to make local anaesthetics safer have been handed major cash boosts. The Medtech Accelerator programme, which is run in partnership with the New Anglia Local Enterprise Partnership (LEP), awarded grants of £80,000 to £125,000 to four projects across East Anglia including two […]

Start Up to Commercialise Pioneering Ablation Treatment

Medical device company Ablatus Therapeutics Ltd, has been founded to develop and commercialise a novel tissue ablation technology to treat the most challenging and often inoperable, solid cancer tumours. Spun-out of Norfolk & Norwich University Hospitals NHS Foundation Trust (NNUH) with support from Health Enterprise East (HEE), investment totalling £500K comes from Anglia Capital Group, […]

Ablatus is treated to $648,000

UK government-created and EU-backed institutions support Ablatus Therapeutics in its $648,000 round to commercialise a potential treatment for solid cancer tumours. Ablatus Therapeutics, a UK-based medical device spinout from Norfold and Norwich University Hospitals NHS Foundation Trust, has raised £500,000 ($648,000) from a consortium including the Low Carbon Innovation Fund. The Low Carbon Innovation Fund, […]

Ablatus Therapeutics founded to develop and commercialise pioneering cancer treatment

Ablatus Therapeutics Ltd, a medical device company, has been founded to develop and commercialise a novel tissue ablation technology to treat the most challenging and often inoperable, solid cancer tumours. Spin out company raises £500k seed funding to progress development towards CE-marking and human studies The start-up company has spun-out of Norfolk & Norwich University […]